Vertex Pharmaceuticals Inc / Ma
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 42,576 | 0.3% | 93,837 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 38,427 | 0.3% | 98,153 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 41,694 | 0.4% | 93,689 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 47,664 | 0.5% | 98,221 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 35,434 | 0.4% | 87,796 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 42,931 | 0.4% | 92,327 | 9/30/2024 |
| 2024 Q2 | 8/6/2024 | 37,707 | 0.5% | 80,401 | 6/30/2024 |
| 2024 Q1 | 5/13/2024 | 49,364 | 0.7% | 118,245 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 47,524 | 0.7% | 116,798 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 46,306 | 0.6% | 133,444 | 9/30/2023 |
| 2023 Q2 | 8/4/2023 | 47,536 | 0.6% | 135,076 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 42,068 | 0.5% | 133,534 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 37,420 | 0.5% | 129,492 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 36,112 | 0.6% | 124,795 | 9/30/2022 |
| 2022 Q2 | 8/8/2022 | 22,402 | 0.3% | 79,509 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 19,670 | 0.3% | 72,852 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 16,574 | 0.2% | 74,639 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 4,511 | 0.1% | 24,809 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 5,313 | 0.1% | 25,646 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 3,591 | 0.1% | 16,793 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 5,086 | 0.1% | 21,522 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 3,033 | 0.1% | 11,148 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 2,359 | 0.1% | 8,129 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 2,606 | 0.1% | 10,956 | 3/31/2020 |
| 2019 Q4 | 2/13/2020 | 2,269 | 0.1% | 10,364 | 12/31/2019 |